SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
9 references·0 citing·35 second hop
COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process? (2022)COVID-19 Vaccines: How Efficient and Equi…The Race for Global Equitable Access to COVID-19 Vaccines (2022)The Race for Global Equitable…Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines (2022)Estimates of the Global Burde…COVAX, vaccine donations and the politics of global vaccine inequity (2022)COVAX, vaccine donations and …COVAX and equitable access to COVID-19 vaccines (2022)COVAX and equitable access to…Addressing Vaccine Inequity — Covid-19 Vaccines as a Global Public Good (2022)Addressing Vaccine Inequity —…Risky business: COVAX and the financialization of global vaccine equity (2021)Risky business: COVAX and the…International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility (2021)International Collaboration t…Global impact of vaccine nationalism during COVID-19 pandemic (2021)Global impact of vaccine nati…Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment (2021)Challenges in ensuring global…Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012 (2014)Vaccine hesitancy: Definition, scope and determinants (2015)A global survey of potential acceptance of a COVID-19 vaccine (2020)COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries (2021)Understanding COVID-19 vaccine hesitancy (2021)Risk Society, Towards a New Modernity (1994)Risk Society: Towards a New Modernity (1995)The financialization of the American economy (2005)Discovering temporal scientometric knowledge in COVID-19 scholarly production (2022)Global inequities in access to COVID-19 health products and technologies: A political economy analysis (2023)COVID-19 and the Cost of Vaccine Nationalism (2020)How COVID vaccines are being divvied up around the world (2020)Disparities in COVID-19 Vaccination among Low-, Middle-, and High-Income Countries: The Mediating Role of Vaccination Policy (2021)The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa (2023)Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia (2024)A global database of COVID-19 vaccinations (2021)Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders. (2022)Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-Saharan Africa (2023)Vaccine access, equity and justice: COVID-19 vaccines and vaccination (2023)China's Health Diplomacy in Africa (2010)COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps (2022)What the COVID-19 pandemic revealed about intellectual property (2022)On the measurement of inequalities in health (1991)Measuring socioeconomic inequality in health, health care and health financing by means of rank-dependent indices: A recipe for good practice (2011)COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities (2024)Global COVID-19 vaccination challenges: Inequity of access and vaccine hesitancy (2025)Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword (2025)Health outcomes in economic evaluation: the QALY and utilities (2010)The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks (2021)It is not too late to achieve global covid-19 vaccine equity (2022)COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries (2021)Ending vaccine hegemony: Rethinking foreign aid in global health responses (2025)COVAX and the rise of the ‘super public private partnership’ for global health (2021)COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions (2021)Global COVID-19 vaccine inequity: The scope, the impact, and the challenges (2021)
this work references cited by second hop

References

  • 2021Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment1,291 cited
  • 2021International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility210 cited
  • 2022COVAX, vaccine donations and the politics of global vaccine inequity141 cited
  • 2022Addressing Vaccine Inequity — Covid-19 Vaccines as a Global Public Good107 cited
  • 2022The Race for Global Equitable Access to COVID-19 Vaccines78 cited
  • 2021Global impact of vaccine nationalism during COVID-19 pandemic72 cited
  • 2021Risky business: COVAX and the financialization of global vaccine equity67 cited
  • 2022COVAX and equitable access to COVID-19 vaccines51 cited
  • 2022Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines24 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work